| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |